ReviewIndian journal of psychiatry2026
The prevalence of anxiety disorders among people living with HIV in India: A systematic review and meta-analysis.
Review in Indian journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Globally, 301 million face anxiety disorders, notably common among people living with human immunodeficiency virus (PLHIV), causing major challenges and reduced quality of life. Aim: This review assesses India's prevalence, offering evidence to guide targeted interventions. Methods: A systematic literature search was conducted across PubMed, Excerpta Medica database (EMBASE), Scopus, and Web of Science up to November 2024. Observational studies using validated tools to assess anxiety prevalence in PLHIV were included. The pooled prevalence of anxiety disorders was estimated using a random-effects meta-analysis. Subgroup and sensitivity analyses were conducted to explore sources of heterogeneity. Study quality was assessed using the Joanna Briggs Institute Critical Appraisal Tool. Between-study heterogeneity was evaluated using Cochran's Q and I² statistics. Results: Fifteen studies (5,336 PLHIV) were included. The pooled prevalence of anxiety was 36% (95% confidence interval: 24%-47%), with higher prevalence in hospital-based studies (39%) compared to community-based studies (23%). Females had a higher prevalence (46%) than males (36%), though this difference was not statistically significant. Diagnostic tools influenced prevalence estimates, with self-report measures (e.g., Hospital Anxiety and Depression Scale [HADS] and Depression Anxiety and Stress Scale [DASS]) reporting higher prevalence (48%-49%) than structured interviews (ICD-10: 7%, DSM-IV: 1%). Subgroup analysis revealed significant heterogeneity across study settings and diagnostic tools. Conclusion: This meta-analysis demonstrates a high prevalence of anxiety disorders among PLHIV in India, underscoring the need for integrated mental health services within HIV care frameworks. Routine anxiety screening, stigma reduction initiatives, and gender-sensitive interventions are essential to address this mental health burden effectively. Future research should focus on longitudinal outcomes and community-based approaches to improve mental health care for PLHIV.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.